CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. (CASI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
casi · stock forecast · 6 analysts (3M) · FMP · updated Mar 18, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$6.00
+3900.0% upside
Low
$6.00
Median: $6 · Last Close: $0.15
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.15 | ↑ 3.19% |
1-day model range: $0.15–$0.16. Peak: $0.16 (+3.19%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CASI · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on CASI Pharmaceuticals, Inc. (CASI) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover CASI.
Analyst Recommendation Trends
CASI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$13M
↓ 84.9% YoY
Revenue Next Year
$70M
↑ 421.5% YoY
EPS This Year
$-2.58
EPS Next Year
$-1.41
↓ 45.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast CASI EPS of $-2.58 for the current fiscal year, based on estimates from 1 analysts. The CASI revenue forecast is $13M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CASI stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CASI price target is $6.00 (+3900.0% upside), with an analyst consensus of Buy.
The CASI short-term stock prediction for tomorrow is $0.15 (+3.19%).
CASI Pharmaceuticals, Inc. trades on NASDAQ under the ticker CASI. The CASI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CASI forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month CASI price target is $6.00, with a high forecast of $6.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies +3900.0% potential upside from the current price of $0.15.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.